Bas Cornelis Jansen

Bas Cornelis Jansen

Auto-generated profile, based on publicly available information

Bas Cornelis Jansen

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2015 in Glycoconjugate Journal
Verified
Journal Article
Open access
PDF file
FCFlorent Clerc
Florent Clerc
KRKarli R. Reiding
Karli R. Reiding
BJBas C. Jansen
Bas C. Jansen
Guinevere S.M. Lageveen-KammeijerGuinevere S.M. Lageveen-Kammeijer
Guinevere S.M. Lageveen-Kammeijer
ABAlbert Bondt
Albert Bondt
MWManfred Wuhrer
Manfred Wuhrer
Glycosylation is the most abundant and complex protein modification, and can have a profound structural and functional effect on the conjugate. The oligosaccharide fraction is recognized to be involved in multiple biological processes, and to affect proteins physical properties, and has consequentially been labeled a critical quality attribute of biopharmaceuticals. Additionally, due to recent advances in analytical methods and analysis software, glycosylation is targeted in the search for disease biomarkers for early diagnosis and patient stratification. Biofluids such as saliva, serum or plasma are of great use in this regard, as they are easily accessible and can provide relevant glycosylation information. Thus, as the assessment of protein glycosylation is becoming a major element in clinical and biopharmaceutical research, this review aims to convey the current state of knowledge on the N-glycosylation of the major plasma glycoproteins alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-1B-glycoprotein, alpha-2-HS-glycoprotein, alpha-2-macroglobulin, antithrombin-III, apolipoprotein B-100, apolipoprotein D, apolipoprotein F, beta-2-glycoprotein 1, ceruloplasmin, fibrinogen, immunoglobulin (Ig) A, IgG, IgM, haptoglobin, hemopexin, histidine-rich glycoprotein, kininogen-1, serotransferrin, vitronectin, and zinc-alpha-2-glycoprotein. In addition, the less abundant immunoglobulins D and E are included because of their major relevance in immunology and biopharmaceutical research. Where available, the glycosylation is described in a site-specific manner. In the discussion, we put the glycosylation of individual proteins into perspective and speculate how the individual proteins may contribute to a total plasma N-glycosylation profile determined at the released glycan level.

17 June 2016 in Journal of Proteome Research
Verified
Journal Article
Closed access
BJBas C. Jansen
Bas C. Jansen
DFDavid Falck
David Falck
NHNoortje de Haan
Noortje de Haan
AEAgnes Hipgrave Ederveen
Agnes Hipgrave Ederveen
GRGenadij Razdorov
Genadij Razdorov
MWManfred Wuhrer
Manfred Wuhrer

1 May 2015 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
RPRosina Plomp
Rosina Plomp
GDGillian Dekkers
Gillian Dekkers
YRYoann Rombouts
Yoann Rombouts
RVRemco Visser
Remco Visser
CKCarolien A.M. Koeleman
Carolien A.M. Koeleman
MWManfred Wuhrer
Manfred Wuhrer
Immunoglobulin G (IgG) is one of the most abundant proteins present in human serum and a fundamental component of the immune system. IgG3 represents ∼8% of the total amount of IgG in human serum and stands out from the other IgG subclasses because of its elongated hinge region and enhanced effector functions. This study reports partial O-glycosylation of the IgG3 hinge region, observed with nanoLC-ESI-IT-MS(/MS) analysis after proteolytic digestion. The repeat regions within the IgG3 hinge were found to be in part O-glycosylated at the threonine in the triple repeat motif. Non-, mono- and disialylated core 1-type O-glycans were detected in various IgG3 samples, both poly- and monoclonal. NanoLC-ESI-IT-MS/MS with electron transfer dissociation fragmentation and CE-MS/MS with CID fragmentation were used to determine the site of IgG3 O-glycosylation. The O-glycosylation site was further confirmed by the recombinant production of mutant IgG3 in which potential O-glycosylation sites had been knocked out. For IgG3 samples from six donors we found similar O-glycan structures and site occupancies, whereas for the same samples the conserved N-glycosylation of the Fc CH2 domain showed considerable interindividual variation. The occupancy of each of the three O-glycosylation sites was found to be ∼10% in six serum-derived IgG3 samples and ∼13% in two monoclonal IgG3 allotypes.

13 November 2015 in Journal of Proteome Research
Verified
Journal Article
Closed access
BJBas C. Jansen
Bas C. Jansen
KRKarli R. Reiding
Karli R. Reiding
ABAlbert Bondt
Albert Bondt
AEAgnes Hipgrave Ederveen
Agnes Hipgrave Ederveen
MPMagnus Palmblad
Magnus Palmblad
MWManfred Wuhrer
Manfred Wuhrer

1 March 2017 in EBioMedicine
Verified
Journal Article
Open access
MKMichael J. Kemna
Michael J. Kemna
RPRosina Plomp
Rosina Plomp
PPPieter van Paassen
Pieter van Paassen
CKCarolien A.M. Koeleman
Carolien A.M. Koeleman
BJBas C. Jansen
Bas C. Jansen
MWManfred Wuhrer
Manfred Wuhrer
The objective of our study is to investigate the Fc glycosylation profiles of both antigen-specific IgG targeted against proteinase 3 (PR3-ANCA) and total IgG as prognostic markers of relapse in patients with Granulomatosis with Polyangiitis (GPA). Seventy-five patients with GPA and a PR3-ANCA rise during follow-up were included, of whom 43 patients relapsed within a median period of 8 (2-16) months. The N-glycan at Asn297 of affinity-purified and denatured total IgG and PR3-ANCA was determined by mass spectrometry of glycopeptides in samples obtained at the time of the PR3-ANCA rise and at the time of the relapse or time-matched during remission. Patients with total IgG1 exhibiting low galactosylation or low sialylation were highly prone to relapse after an ANCA rise (HR 3.46 [95%-CI 1.73-6.96], p<0.0001 and HR 3.22 [95%-CI 1.52-6.83], p=0.002, respectively). In relapsing patients, total IgG1 galactosylation, sialylation and bisection significantly decreased and fucosylation significantly increased from the time of the PR3-ANCA rise to the relapse (p<0.0001, p=0.0087, p<0.0001 and p=0.0025), while the glycosylation profile remained similar in non-relapsing patients. PR3-ANCA IgG1 galactosylation, sialylation and fucosylation of PR3-ANCA IgG1 decreased in relapsing patients (p=0.0073, p=0.0049 and p=0.0205), but also in non-relapsing patients (p=0.0007, p=0.0114 and p=0.0002), while bisection increased only in non-relapsing patients (p<0.0001). While Fc glycosylation profiles have been associated with clinically manifest autoimmune diseases, in the present study we show that low galactosylation and sialyation in total IgG1 but not PR3-ANCA IgG1 predicts disease reactivation in patients with GPA who experience an ANCA rise during follow-up. We postulate that glycosylation profiles may be useful in pre-emptive therapy studies using ANCA rises as guideline.

16 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Guinevere S.M. Lageveen-KammeijerGuinevere S.M. Lageveen-Kammeijer
Guinevere S.M. Lageveen-Kammeijer
BJBas C. Jansen
Bas C. Jansen
IKIsabelle Kohler
Isabelle Kohler
AHAnthonius A. M. Heemskerk
Anthonius A. M. Heemskerk
OMOleg A. Mayboroda
Oleg A. Mayboroda
MWManfred Wuhrer
Manfred Wuhrer
Sialylation is a glycosylation feature that occurs in different linkages at the non-reducing end of a glycan moiety, the linkage isomers are often differentially associated with various biological processes. Due to very similar physico-chemical properties, the separation of isomeric sialylated glycopeptides remains challenging but of utmost importance in the biomedicine and biotechnology, including biomarker discovery, glyco-engineering and biopharmaceutical characterization. This study presents the implementation of a high-resolution separation platform based on capillary electrophoresis – mass spectrometry (CE–MS) allowing for the selective analysis of α2,3- and α2,6-sialylated glycopeptides. These differentially linked glycopeptides showed an identical fragmentation pattern (collision induced dissociation) but different electrophoretic mobilities, allowing for baseline separation of the different linkages without the need for an extensive sample preparation. The different migration behavior between the two moieties was found to correlate with differences in pKavalues. Using a novel methodology adapted from the so-called internal standard CE approach, a relative difference of 3.4·10−2in pKaunit was determined. This approach was applied for the analysis of tryptic glycopeptides of prostate specific antigen, which shows highly complex and heterogeneous glycosylation. The developed platform therefore appears attractive for the identification of differentially linked sialic acids that may be related to pathological conditions.